Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription 25.08.2025 8 Am J Cardiol 1 Am J Emerg Med 5 Angiology 3 Ann Intern Med 2 Ann Thorac Surg 1 Atherosclerosis 5 Can J Cardiol 2 Cardiovasc Res 2 Catheter Cardiovasc Interv 1 Chest 5 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 1 Circ Heart Fail 1 Circ J 3 Circulation 4 Eur Heart J 2 Heart 10 Int J Cardiol 5 J Am Coll Cardiol 1 J Cardiovasc Pharmacol 2 J Clin Endocrinol Metab 3 J Electrocardiol 3 J Thorac Cardiovasc Surg 1 Lancet 3 PLoS One 1 Thromb Haemost

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. HE Y, Wu H, Luo Y, Wen X, et al
   The Relationship Between Sleep Duration and Cardiovascular Disease: A Prospective Cohort Study Based on CHARLS.
   Am J Cardiol. 2025 Aug 13:S0002-9149(25)00466.
   PubMed         Abstract available
   
   
2. GURGOGLIONE FL, Iwanczyk S, Wanha W, Donelli D, et al
   Sirolimus-Coated Balloon vs. Drug-Eluting Stent in Elderly Patients With Coronary Artery Disease: A Matched-based Comparison.
   Am J Cardiol. 2025 Aug 13:S0002-9149(25)00464.
   PubMed         Abstract available
   
   
3. TIEMUERNIYAZI X, Chen L, He L, Yang Z, et al
   The role of angiotensin receptor/neprilysin inhibitor in moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting (ARNI-MIMIC): study protocol for a randomized controlled trial.
   Am J Cardiol. 2025 Aug 21:S0002-9149(25)00489.
   PubMed         Abstract available
   
   
4. SHI Y, Liu J
   Impact of Myocardial Bridging on Hemodynamics Evaluated by Coronary Angiography-Derived Fractional Flow Reserve.
   Am J Cardiol. 2025 Aug 21:S0002-9149(25)00485.
   PubMed         Abstract available
   
   
5. AL-GULLY J, Montero-Cabezas JM, Eikenboom J, den Exter PL, et al
   Diagnosis and Treatment of Unrecognized Spontaneous Coronary Artery Dissection in Young Women Presenting with an Acute Coronary Syndrome.
   Am J Cardiol. 2025 Aug 16:S0002-9149(25)00477.
   PubMed         Abstract available
   
   
6. PEI Y, Xu H, Pan C, Zhu F, et al
   Implication of Angio-based Microvascular Resistance, a Measure of Coronary Microvascular Dysfunction Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
   Am J Cardiol. 2025 Aug 16:S0002-9149(25)00478.
   PubMed         Abstract available
   
   
7. MUKHERJEE D
   Drug Coated Balloons for the Treatment of Coronary Artery Disease.
   Am J Cardiol. 2025 Aug 14:S0002-9149(25)00463.
   PubMed        
   
   
8. WANG Q, Sui YX, Zhang LT, Meng N, et al
   Systemic Review of Inflammatory Pathways and Immune Modulation In Atherosclerotic Cardiovascular Disease.
   Am J Cardiol. 2025 Aug 14:S0002-9149(25)00465.
   PubMed         Abstract available
   
   

   
   Am J Emerg Med

9. SNAVELY A, Jackson L, Hunter CJ, Murtagh G, et al
   Differentiating Type 1 and Type 2 myocardial infarction using a machine learning algorithm and biomarkers.
   Am J Emerg Med. 2025;98:50-56.
   PubMed         Abstract available
   
   

   
   Angiology

10. CHEN S, Zhu B, Luo Z, Wang Y, et al
    The Fibrosis-5 Index Predicts Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Angiology. 2025;76:734-742.
    PubMed         Abstract available
    
    
11. HYASAT K, Hasche E, Almafragy H, Chiha J, et al
    Fractional Flow Reserve and Angiography Guided Complete Revascularization in Primary Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.
    Angiology. 2025;76:720-733.
    PubMed         Abstract available
    
    
12. SAYLIK F, Kumet O, Sarikaya R, Akbulut T, et al
    Bendopnea Predicts High SYNTAX Score in Patients With Coronary Artery Disease: A Bayesian Approach.
    Angiology. 2025;76:743-750.
    PubMed         Abstract available
    
    
13. ISSA R, Calcagno T, Canova T, Issa R, et al
    Outcomes Associated With SGLT2 Inhibitor Use Following Acute Myocardial Infarction Without Heart Failure: A Propensity-Matched Study.
    Angiology. 2025 Aug 25:33197251365016. doi: 10.1177/00033197251365016.
    PubMed         Abstract available
    
    
14. CAP M, Yap NAL, Bourantas CV
    Response to the Letter to the Editor: "An Automated User-Friendly Software for Fast Computation of Blood Flow Velocity From Coronary Angiographic Images".
    Angiology. 2025 Aug 22:33197251368951. doi: 10.1177/00033197251368951.
    PubMed        
    
    

    
    Ann Intern Med

15. PAGANO MB, Stanworth SJ, Dennis J, Bakhtary S, et al
    Red Cell Transfusion in Acute Myocardial Infarction: AABB International Clinical Practice Guidelines.
    Ann Intern Med. 2025 Aug 19. doi: 10.7326/ANNALS-25-00706.
    PubMed         Abstract available
    
    
16. OGUNTALA JO, Yan AT
    Toward Evidence-Based Transfusion for Anemia in Acute Myocardial Infarction: Still an Unfinished Story.
    Ann Intern Med. 2025 Aug 19. doi: 10.7326/ANNALS-25-02486.
    PubMed        
    
    
17. CENTOR RM, Kip K, Saeed A
    Web Exclusive. Annals On Call - Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes.
    Ann Intern Med. 2025;178:e2503594OC.
    PubMed        
    
    

    
    Ann Thorac Surg

18. SCHENA S, Garcia-Villarreal OA
    Surgical Ablation of Atrial Fibrillation in Addition to Coronary Artery Bypass Grafting: Are We Muddying the Waters?
    Ann Thorac Surg. 2025 Aug 22:S0003-4975(25)00774.
    PubMed        
    
    
19. JONES-UNGERLEIDER KC, Yang B
    Coronary Artery Bypass Grafting in Acute Type A Aortic Dissection.
    Ann Thorac Surg. 2025 Aug 22:S0003-4975(25)00777.
    PubMed        
    
    

    
    Atherosclerosis

20. CANDREVA A, Morbiducci U, Erriquez A, Rizzini ML, et al
    Enhanced coronary physiology assessment with endothelial shear stress predicts residual cardiovascular risk in older patients with myocardial infarction.
    Atherosclerosis. 2025;409:120476.
    PubMed         Abstract available
    
    

    
    Can J Cardiol

21. WONG HJ, Low CE, Yau CE, Teo YH, et al
    Optimization of Guideline-Directed Medical Therapy Prescription after First-onset Myocardial Infarction in the Very Elderly.
    Can J Cardiol. 2025 Aug 22:S0828-282X(25)01035.
    PubMed        
    
    
22. SHENG Z, Che W, An S, Zhang Z, et al
    Assessing Coronary Microvascular Dysfunction Using Angiographic Frame Count in Patients With Angina and Nonobstructive Coronary Arteries.
    Can J Cardiol. 2025;41:1446-1455.
    PubMed         Abstract available
    
    
23. POLETTI E, Kearney KE, Chung CJ, Elison D, et al
    Predicting Mortality and Periprocedural Adverse Events in Patients Undergoing Complex and Higher Risk Percutaneous Coronary Intervention.
    Can J Cardiol. 2025;41:1434-1442.
    PubMed         Abstract available
    
    
24. ABDELGHANI M, Hemetsberger R, Hassan A, Abdelshafy M, et al
    Acute Coronary Syndromes after Transcatheter Aortic Valve Implantation: Incidence, Unique Mechanisms, and Outcomes.
    Can J Cardiol. 2025;41:1628-1637.
    PubMed         Abstract available
    
    
25. GUPTA AK, Mustafiz C, Mutahar D, Zaka A, et al
    Machine Learning vs Traditional Approaches to Predict All-Cause Mortality for Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2025;41:1564-1583.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

26. HADAYA J, Boukens BJD, Janse MJ, Cha S, et al
    Right stellate ganglion stimulation modulates arrhythmogenesis in acute left lateral ventricular ischaemia.
    Cardiovasc Res. 2025;121:1385-1391.
    PubMed         Abstract available
    
    
27. GUTMANN C, Barwari T, Schulte C, Theofilatos K, et al
    Platelets and inflammation-insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial.
    Cardiovasc Res. 2025;121:1392-1406.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

28. SHAVAZI MT, Sadr S, Ayoubpour MR, Mostafavi S, et al
    Anomalous Single Ostial Origin of Entire Coronary Arteries From the Right Coronary Sinus: A Rare Case of ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
    Catheter Cardiovasc Interv. 2025 Aug 24. doi: 10.1002/ccd.70128.
    PubMed         Abstract available
    
    
29. WARREN J, Ball J, Dawson L, Nehme E, et al
    Incidence and Predictors of Referral for Coronary Angiography and Revascularization in Non-ST-Segment Elevation Myocardial Infarction.
    Catheter Cardiovasc Interv. 2025 Aug 25. doi: 10.1002/ccd.70111.
    PubMed         Abstract available
    
    

    
    Chest

30. PEKER Y, Celik Y, Zinchuk A, Sands SA, et al
    Hypoxic Burden is Associated with Cardiovascular Events: A Risk Stratification Analysis of the RICCADSA Cohort.
    Chest. 2025 Aug 14:S0012-3692(25)05023-8. doi: 10.1016/j.chest.2025.07.4081.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

31. PARGAONKAR VS, Wong CCY, Honda Y, Schnittger I, et al
    Invasive Coronary Function Testing in Patients With Prior PCI Who Have Persistent ANOCA.
    Circ Cardiovasc Interv. 2025;18:e015344.
    PubMed         Abstract available
    
    
32. PHICHAPHOP A, Sorajja P, Enriquez-Sarano M, Fukui M, et al
    Feasibility of Computed Tomography as a Gatekeeper for Invasive Angiography Before TAVR: A Pragmatic Real-World Experience.
    Circ Cardiovasc Interv. 2025 May 21:e015181.
    PubMed         Abstract available
    
    
33. DEGRAUWE S, Fahrni G, Kaiser C, Dupre M, et al
    Contemporary Look Into Spontaneous Coronary Artery Dissection: The SwissSCAD Registry.
    Circ Cardiovasc Interv. 2025 Aug 22:e015540.
    PubMed        
    
    
34. BASALA T, Seth M, Madder RD, Wanamaker B, et al
    Safety and Effectiveness of Intracoronary Imaging-Guided PCI in Contemporary Practice: Insights From BMC2.
    Circ Cardiovasc Interv. 2025 Aug 19:e014886.
    PubMed         Abstract available
    
    
35. DEMIR OM, Rahman H, Perera D
    Response by Demir et al to Letter Regarding Article, "Pressure Derived Indices in the Left Main Coronary Artery: Insights From Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels".
    Circ Cardiovasc Interv. 2025 Aug 19:e015752.
    PubMed        
    
    

    
    Circ Cardiovasc Qual Outcomes

36. DANIELS LB, Peacock WF, Lindahl B, de Lemos JA, et al
    Disrupting the Status Quo: Reimagining How We Use Troponin for Diagnosing Myocardial Infarction.
    Circ Cardiovasc Qual Outcomes. 2025 Aug 21:e012131.
    PubMed        
    
    

    
    Circ Heart Fail

37. BAUDRY G, Girerd N, Duarte K, Monzo L, et al
    Sex-Related Prognosis of VA-ECMO-Treated Cardiogenic Shock: A Post-Hoc Analysis of the HYPO-ECMO Trial.
    Circ Heart Fail. 2025 May 20. doi: 10.1161/CIRCHEARTFAILURE.124.012702.
    PubMed         Abstract available
    
    

    
    Circ J

38. KAWAMURA A, Shimamura K, Yoshioka D, Misumi Y, et al
    Estimation of Coronary Obstruction Risk for the Transcatheter Aortic Valve Implantation in Surgical Aortic Valve (TAV-in-SAV) Procedure.
    Circ J. 2025;89:1472-1479.
    PubMed         Abstract available
    
    

    
    Circulation

39. QIN D, Modanwal R, Ghazi M, Corbalan JJ, et al
    Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.
    Circulation. 2025;152:486-488.
    PubMed        
    
    
40. WU J, Zheng Y
    Letter by Wu and Zheng Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e67.
    PubMed        
    
    
41. HO FK, Sattar N, Welsh P
    Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e68.
    PubMed        
    
    

    
    Eur Heart J

42. ALI ZA, Shin D, Vijayvergiya R, Gawalkar AA, et al
    Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial.
    Eur Heart J. 2025 Jun 5:ehaf331. doi: 10.1093.
    PubMed         Abstract available
    
    
43. BAY B, Tanner R, Gao M, Oliva A, et al
    Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary interventiondagger.
    Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093.
    PubMed         Abstract available
    
    
44. HANSSON EC, Omerovic E, Venetsanos D, Alfredsson J, et al
    Coronary artery bypass grafting with or without preoperative physiological stenosis assessment: a SWEDEHEART study.
    Eur Heart J. 2025 May 16:ehaf327. doi: 10.1093.
    PubMed         Abstract available
    
    
45. KIM MC, Park SJ, Park DW, Ahn JM, et al
    Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trial.
    Eur Heart J. 2025 May 29:ehaf273. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

46. VERMA A, Chervu NL, Kim JJ, Mallick S, et al
    Variation in mechanical circulatory support use for acute myocardial infarction cardiogenic shock.
    Heart. 2025 Aug 24:heartjnl-2024-325413. doi: 10.1136/heartjnl-2024-325413.
    PubMed         Abstract available
    
    
47. OCCHIPINTI G, Brugaletta S, Abbate A, Pedicino D, et al
    Inflammation in coronary atherosclerosis: diagnosis and treatment.
    Heart. 2025;111:801-810.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

48. POLLER A, Bech-Hanssen O, Redfors B
    Reply to comment on "Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction" by Poller et al.
    Int J Cardiol. 2025 Aug 20:133801. doi: 10.1016/j.ijcard.2025.133801.
    PubMed        
    
    
49. NILSEN DWT, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    Reply to: Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients.
    Int J Cardiol. 2025 Aug 19:133807. doi: 10.1016/j.ijcard.2025.133807.
    PubMed        
    
    
50. LONN A, Carroll SJ, Niyonsenga T, Bauman A, et al
    Reply to comment on associations between change in moderate-to-vigorous physical activity and sedentary behaviour with risk of recurrent cardiovascular events among individuals with coronary heart disease: A prospective cohort study.
    Int J Cardiol. 2025 Aug 17:133800. doi: 10.1016/j.ijcard.2025.133800.
    PubMed        
    
    
51. DWT N, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    Reply to: Reinterpreting interleukin-1 receptor antagonist elevation in acute myocardial infarction.
    Int J Cardiol. 2025 Aug 17:133797. doi: 10.1016/j.ijcard.2025.133797.
    PubMed        
    
    
52. SU X, Qiu M, Liu H, Xu K, et al
    Prolonged dual antiplatelet therapy strategy in acute coronary syndrome patients post-standard therapy and adverse event-free: An analysis based on OPT-CAD risk score stratification.
    Int J Cardiol. 2025;439:133636.
    PubMed         Abstract available
    
    
53. GIACOBBE F, Bruno F, Giannino G, Angelini F, et al
    Safety and efficacy of P2Y12 inhibitors in acute coronary syndromes patients with KDIGO stage IV-V renal disfunction not on dialysis: a subanalysis of the CORALYS registry.
    Int J Cardiol. 2025;439:133613.
    PubMed         Abstract available
    
    
54. TIAN J, Wang Y
    Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
    Int J Cardiol. 2025 Aug 21:133811. doi: 10.1016/j.ijcard.2025.133811.
    PubMed        
    
    
55. NILSEN DWT, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    Reply to: Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
    Int J Cardiol. 2025 Aug 22:133812. doi: 10.1016/j.ijcard.2025.133812.
    PubMed        
    
    
56. TOGNOLA C, Bernasconi D, Intravaia RCM, Brioschi G, et al
    Prevalence of hypertriglyceridemia and its association with extreme cardiovascular risk in patients with acute and chronic coronary syndrome enrolled in a cardiac rehabilitation program.
    Int J Cardiol. 2025;439:133608.
    PubMed         Abstract available
    
    
57. LI F, Zhang JJ, Ruan GJ, Zhan YY, et al
    Prediction models for no-reflow phenomenon after PCI in acute coronary syndrome patients: A systematic review.
    Int J Cardiol. 2025;439:133603.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

58. TAN S, Nelson AJ, Muthalaly RG, Nerlekar N, et al
    Pop-Up Cardiovascular Screening Within Community Pharmacies and an International Sporting Event.
    J Am Coll Cardiol. 2025 Aug 4:S0735-1097(25)07177.
    PubMed         Abstract available
    
    
59. ARUN AS, Sawano M, Lu Y, Warner F, et al
    Update to the JACC Report Card: Excess Cardiovascular Mortality Among Black Americans, 2000-2023.
    J Am Coll Cardiol. 2025;86:559-562.
    PubMed        
    
    
60. A HEIDENREICH P, Bhatt A, Nazir NT, Schaffner W, et al
    2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Adult Immunizations as Part of Cardiovascular Care: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07089.
    PubMed        
    
    
61. BONGIOVANNI D, Landi A, Frigoli E, Heg D, et al
    Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR Patient.
    J Am Coll Cardiol. 2025 May 7:S0735-1097(25)06483.
    PubMed         Abstract available
    
    
62. YANG S, Hu X, Zhang J, Jiang J, et al
    Long-Term Outcomes After Fractional Flow Reserve vs Intravascular Ultrasound to Guide PCI: The FLAVOUR Trial Extended Follow-Up.
    J Am Coll Cardiol. 2025;86:593-606.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

63. MA M, Xu C, Zhou H, Zhou Y, et al
    Lactylation in Cardiovascular Diseases: Epigenetic Mechanisms and Therapeutic Potential.
    J Cardiovasc Pharmacol. 2025 Aug 15. doi: 10.1097/FJC.0000000000001751.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

64. HASEBE M, Su CY
    Letter to the Editor from Hasebe and Su: "Increased Risk of Cardiovascular Diseases in Patients With Chronic Hypoparathyroidism in Sweden".
    J Clin Endocrinol Metab. 2025 Aug 25:dgaf474. doi: 10.1210.
    PubMed        
    
    
65. BJORNSDOTTIR S, Mannstadt M, Clarke B, Spelman T, et al
    Response to Letter to the Editor From Hasebe and Su: "Higher risk of cardiovascular diseases in patients with chronic hypoparathyroidism in Sweden".
    J Clin Endocrinol Metab. 2025 Aug 25:dgaf475. doi: 10.1210.
    PubMed        
    
    

    
    J Electrocardiol

66. YANG KX, von Scheele J, Maanja M, Loewenstein DE, et al
    Explainable advanced electrocardiography at rest for ruling out myocardial ischemia on stress echocardiography.
    J Electrocardiol. 2025;91:154028.
    PubMed         Abstract available
    
    
67. KAHYAOGLU M, Sengor BG, Demirbas MI, Gecmen C, et al
    ECG-derived DETERMINE score can provide information about procedure success in chronic total occlusion patients.
    J Electrocardiol. 2025;91:154022.
    PubMed         Abstract available
    
    
68. FENG L, Lin Z, Ji Y, Lim PO, et al
    Post-infarct lateral extension-Brody effect or stent thrombosis?
    J Electrocardiol. 2025;91:154014.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

69. LIU TX, McCarthy PM, Manerikar A, Won D, et al
    Automated and Explainable Coronary Angiogram Interpretation for Selection of Coronary Artery Bypass Grafting Candidates using Artificial Intelligence.
    J Thorac Cardiovasc Surg. 2025 Aug 14:S0022-5223(25)00655.
    PubMed         Abstract available
    
    
70. GARCIA-VILLARREAL OA
    The primary driver of survival after mitral valve surgery in functional mitral regurgitation: The role of concomitant coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2025 Aug 22:S0022-5223(25)00645.
    PubMed        
    
    
71. ROSARIO J, Jindani R, Uehara M
    At-risk populations for poor outcomes post-coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2025 Aug 25:S0022-5223(25)00649.
    PubMed        
    
    

    
    Lancet

72. ROSSIGNOL P, Zannad F, Massy Z, Azizi M, et al
    Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis.
    Lancet. 2025;406:705-718.
    PubMed         Abstract available
    
    

    
    PLoS One

73. ZHAO L, Ruze A, Du GL, Gai MT, et al
    Ischemic duration determines extent of cardiac remodeling, and both early and delayed reperfusion prevent fatal cardiac rupture: Model comparison.
    PLoS One. 2025;20:e0328001.
    PubMed         Abstract available
    
    
74. WONGYIKUL P, Phinyo P, Suwannasom P, Tantraworasin A, et al
    Cost-utility analysis of Coronary Artery Calcium screening to guide statin prescription among intermediate-risk patients in Thailand.
    PLoS One. 2025;20:e0330425.
    PubMed         Abstract available
    
    
75. SALBACH C, Yildirim M, Milles BR, Hund H, et al
    Improvement in risk prediction for patients with atrial fibrillation and intermediate-risk CHA2DS2-VASc score utilizing highly sensitive cardiac troponin T.
    PLoS One. 2025;20:e0330164.
    PubMed         Abstract available
    
    

    
    Thromb Haemost

76. WU Y, Wang H, Wang Z, Hua C, et al
    Identifying Risk Factors for Left Ventricular Thrombus in Patients with Ischemic Left Ventricular Aneurysm Using Cardiac MRI.
    Thromb Haemost. 2025;125:908-915.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.